Cyclosporine - Isotope Labelled Standards
References
FAQ's
References
- Haerri, Eugen; Rueegger, Artur, Organic compounds, US4117118A, Mar 29, 1977, Sandoz A.-G., Switzerland (https://www.lens.org/lens/search/patent/list?q=US4117118)
- Niederberger, W.; Schaub, P.; Beveridge, T., High-performance liquid chromatographic determination of cyclosporin A in human plasma and urine, Journal of Chromatography, Biomedical Applications, Volume: 182, Issue: 3-4, Pages: 454-8, 1980 DOI: (10.1016/s0378-4347(00)81500-5)
Frequently Asked Questions
2. Which analytical method separates the major degradation products of Cyclosporine from the drug product?
Cyclodextrin-modified micellar electrokinetic chromatography (CD-MEKC). is the analytical method that separates the major degradation products of Cyclosporine from the drug product.
3. How do we detect the degradation products and impurities of Cyclosporine in the drug product?
HPLC method can detect the degradation products and impurities of Cyclosporine in the drug product.
4. Why is it necessary to eliminate the Cyclosporine degradation products and impurities from the drug?
Cyclosporine degradation products and impurities affect drug safety and human health. And so, it is necessary to eliminate them from the drug.
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.